It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This study was conducted to clarify the relationship between thyroid function and gastrointestinal motility. We established an experimental configuration in which the feedback of thyroid function was completely removed using conscious dogs. With hypothyroidism, time of phase I of interdigestive migrating contractions (IMC) was longer, time of phase II and phase III was significantly shortened, and both the continuous time of strong tetanic contraction at antrum and 10-h frequency of phase III counted from the first IMC after meal significantly decreased. Whereas, hyperthyroidism caused the opposite events to those with hypothyroidism. Furthermore, We found giant migrating contractions (GMC) occurred from the upper gastrointestinal tract when we administrated high dose of thyroid hormone. One GMC occurred from anal sides propagated to cardiac, and this propagation was similar to the emesis-like interdigestive motor activity, the other GMC occurred from oral sides propagated to anal sides and this was similar to the diarrhea-like interdigestive motor activity. We examined the relationship between thyroid function and gastrointestinal hormones including of ghrelin, GLP-1, and cholecystokinin (CCK). However, we could not find significant differences under different thyroid hormone status. This is the first report that thyroid hormone activated upper gastrointestinal motility without mediating gastrointestinal hormones.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Gunma University Graduate School of Medicine, Department of General Surgical Science, Maebashi, Japan (GRID:grid.256642.1) (ISNI:0000 0000 9269 4097)
2 Kiryu Kosei General Hospital, Department of Surgery, Kiryu, Japan (GRID:grid.256642.1)
3 Gunma Prefectural Cancer Center, Department of Surgery, Ota, Japan (GRID:grid.256642.1)
4 Daiichi Hospital, Department of Surgery, Takasaki, Japan (GRID:grid.256642.1)
5 Gunma University Graduate School of Medicine, Department of General Surgical Science, Maebashi, Japan (GRID:grid.256642.1) (ISNI:0000 0000 9269 4097); Gunma University Initiative for Advanced Research (GIAR), Division of Integrated Oncology Research, Maebashi, Japan (GRID:grid.256642.1) (ISNI:0000 0000 9269 4097)
6 Gunma University Graduate School of Medicine, Department of Bioresource Center, Maebashi, Japan (GRID:grid.256642.1) (ISNI:0000 0000 9269 4097)
7 Saitama Medical Center, Saitama Medical University, Department of Digestive Tract and General Surgery, Kawagoe, Japan (GRID:grid.256642.1)
8 Gunma University, Department of Integrative Physiology, Graduate School of Medicine, Maebashi, Japan (GRID:grid.256642.1) (ISNI:0000 0000 9269 4097)